chartexchange

GMAB
Genmab A/S ADS
stockNASDAQADR

At CloseOct 2, 2026 3:59:58 PM EDT
34.74USD+0.564%(+0.19)5,436,431
Pre-marketOct 2, 2026 9:27:30 AM EDT
34.51USD-0.116%(-0.04)
After-hoursOct 2, 2026 4:49:30 PM EDT
34.81USD+0.187%(+0.06)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Copenhagen, Koebenhavn V, Denmark
Previous Close
$34.55
Beta
0.75
52-Week High
$35.91 2026-09-30
52-Week Low
$23.62 2026-06-03
SMA 50
$32.67
SMA 200
$29.63
Avg. Vol 10D
3.61M
Avg. Vol 30D
2.55M
Avg. Vol 90D
2.29M
Relative Vol
2.13
624.06M
606.43M
0.7400%
3,000,000
4,958
Nov 5, 2026 (31d)
GMAB Profile

Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund.

GMAB Performance
PeriodPriceDateChangeBeta
1W35.362026-09-28-1.71%-0.140
1M33.602026-09-04+3.44%0.211
3M28.012026-07-06+24.09%0.469
6M27.752026-04-06+25.25%0.447
1Y33.562025-10-03+3.56%0.746
2Y23.492024-10-04+47.96%—
5Y42.602021-10-04-18.41%0.701
GMAB Stock Summary

Genmab A/S ADS (NASDAQ:GMAB) stock price today is $34.76, and today's volume is 5,436,431. GMAB is up 0.598% today. The 30 day average volume is 2.55M. GMAB market cap is $21.69B with 624.06M shares outstanding.